SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-22-013147
Filing Date
2022-04-05
Accepted
2022-04-05 16:16:37
Documents
6
Effectiveness Date
2022-04-05

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10035805_s8.htm S-8 51324
2 EXHIBIT 5.1 brhc10035805_ex5-1.htm EX-5.1 10073
3 EXHIBIT 23.1 brhc10035805_ex23-1.htm EX-23.1 2504
4 EXHIBIT 107 brhc10035805_ex107.htm EX-FILING FEES 28534
5 image0.jpg GRAPHIC 111088
6 image00003.jpg GRAPHIC 2951
  Complete submission text file 0001140361-22-013147.txt   250894
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-264139 | Film No.: 22807048
SIC: 2834 Pharmaceutical Preparations